WallStreetZenWallStreetZen

NASDAQ: APMD
Apnimed Inc Stock Ownership - Who owns Apnimed?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Apnimed Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul J. SekhriDirector2026-08-0312,500$16.00
$200.00kBuy

1 of 1

APMD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APMD insiders and whales buy or sell their stock.

APMD Shareholders

What type of owners hold Apnimed Inc stock?

No data
There are no institutional or insider shareholders.

APMD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABVC3.14%80.87%
ACET28.27%71.73%Net Buying
ABVX63.37%0.00%
ACXP4.23%59.85%
AARD46.75%46.87%Net Buying
View Top Biotech Stocks

Apnimed Stock Ownership FAQ

Who owns Apnimed?

Apnimed (NASDAQ: APMD) is owned by 0.00% institutional shareholders, 1.39% Apnimed insiders, and 98.61% retail investors.

If you're new to stock investing, here's how to buy Apnimed stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.